ECTRIMS 2018

ECTRIMS 2018

DMTs Do Not Moderate Disability in Patients With MS and Diabetes, Other Comorbidities

By

Brandon May

Glatiramer Acetate Associated With Long-Term Disability Improvements in MS

By

Brandon May

Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis

By

Brandon May

High-Dose Biotin May Be an Effective Treatment for Progressive MS

By

Brandon May

MS Relapse Rates After DMT Initiation Similar Between Pediatric-, Adult-Onset MS

By

Brandon May

Lower Relapse Risk and Disability Progression With Oral DMT in Treatment-Naive RRMS

By

Brandon May

Disease Modifying Therapy Associated With Persistent Brain Atrophy Slowing in MS

By

Brandon May

Patients With Multiple Sclerosis Face Greater Infection Risk

By

Brandon May

Alemtuzumab Improves Disability, Prognosis in Treatment-Refractory MS

By

Brandon May

Sexual Dysfunction Prevalent but Underrecognized in Multiple Sclerosis

By

Brandon May